ArrowMark Colorado Holdings’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.91M | Sell |
|
|||||
|
2025
Q1 | $1.7M | Sell |
|
|||||
|
2024
Q4 | $4.43M | Sell |
|
|||||
|
2024
Q3 | $8.69M | Sell |
|
|||||
|
2024
Q2 | $17.8M | Sell |
|
|||||
|
2024
Q1 | $34.4M | Sell |
|
|||||
|
2023
Q4 | $24.3M | Buy |
|
|||||
|
2023
Q3 | $13.8M | Buy |
|
|||||
|
2023
Q2 | $18.6M | Sell |
|
|||||
|
2023
Q1 | $17.8M | Buy |
|
|||||
|
2022
Q4 | $21.8M | Sell |
|
|||||
|
2022
Q3 | $12.3M | Buy |
|
|||||
|
2022
Q2 | $9.94M | Buy |
|
|||||
|
2022
Q1 | $17.3M | Buy |
|
|||||
|
2021
Q4 | $24.4M | Buy |
|
|||||
|
2021
Q3 | $27.1M | Sell |
|
|||||
|
2021
Q2 | $24.8M | Sell |
|
|||||
|
2021
Q1 | $45.5M | Sell |
|
|||||
|
2020
Q4 | $44.1M | Buy |
|